HUTCHMED (CHINA) LIMITED - AMERICAN DEPOSITARY SHA
18.51
30-四月-24 15:59:55
15 分钟延时
股票
-0.40
-2.12%
今日范围
18.40 - 18.89
ISIN
N/A
来源
NASDAQ
-
20 8月 2023 20:00:00 条件 Nasdaq GlobeNewswire
-
HUTCHMED Reports 2023 Interim Results and Provides Business Updates
31 7月 2023 07:41:53 条件 Nasdaq GlobeNewswire
-
HUTCHMED Announces Changes to Board of Directors and Technical Committee
13 7月 2023 04:30:00 条件 Nasdaq GlobeNewswire
-
09 7月 2023 20:00:00 条件 Nasdaq GlobeNewswire
-
HUTCHMED to Announce 2023 Half-Year Financial Results
26 6月 2023 04:30:00 条件 Nasdaq GlobeNewswire
-
HUTCHMED and Takeda Announce Publication of Phase III FRESCO-2 Results in The Lancet
15 6月 2023 20:30:00 条件 Nasdaq GlobeNewswire
-
15 6月 2023 10:30:00 条件 Nasdaq GlobeNewswire
-
09 6月 2023 05:30:00 条件 Nasdaq GlobeNewswire
-
25 5月 2023 19:00:54 条件 Nasdaq GlobeNewswire
-
HUTCHMED Highlights Presentations at the 2023 ASCO Annual Meeting
25 5月 2023 18:00:00 条件 Nasdaq GlobeNewswire
-
HUTCHMED Announces Board of Directors and Board Committee Membership
12 5月 2023 04:30:00 条件 Nasdaq GlobeNewswire
-
HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committees
10 5月 2023 04:30:00 条件 Nasdaq GlobeNewswire
-
HUTCHMED Announces NDA Acceptance in China for Fruquintinib in Second-Line Gastric Cancer
17 4月 2023 20:00:00 条件 Nasdaq GlobeNewswire
-
HUTCHMED Highlights Presentations at American Association for Cancer Research Annual Meeting 2023
11 4月 2023 20:00:00 条件 Nasdaq GlobeNewswire
-
Intended Retirement of Independent Non-executive Director
11 4月 2023 04:30:00 条件 Nasdaq GlobeNewswire
-
04 4月 2023 05:30:00 条件 Nasdaq GlobeNewswire
-
30 3月 2023 20:00:00 条件 Nasdaq GlobeNewswire
-
HUTCHMED Announces Closing of Fruquintinib License to Takeda Outside China
14 3月 2023 09:30:00 条件 Nasdaq GlobeNewswire
-
HUTCHMED Confirms No Assets Held at Silicon Valley Bank
12 3月 2023 20:07:31 条件 Nasdaq GlobeNewswire